Larimar Therapeutics Competitors and Similar CompaniesClear all
Larimar Therapeutics's competitors and similar companies include Lobesity, Oramed Pharmaceuticals, Diapin Therapeutics and Kowa Pharmaceuticals America.
 Larimar Therapeutics Larimar Therapeutics (formerly known as Zafgen) is a biopharmaceutical company dedicated to improving the health and well-being of patients affected by obesity and complex metabolic disorders. |  Lobesity Lobesity (also known as Lobesity Investors) is a company engaged in the clinical and commercial development of therapies to treat obesity and related disorders. |  Oramed Pharmaceuticals Oramed Pharmaceuticals is the developer of an innovative technology to transform injectable treatments into oral therapies. |  Diapin Therapeutics Diapin Therapeutics is a biotech company focused on the treatment of Type 2 diabetes. |  Kowa Pharmaceuticals America Kowa Pharmaceuticals America is a pharmaceutical company focused on cardiometabolic diseases. | |
Founding Date | Founding Date 2005 | Founding Date 2015 | Founding Date 2006 | Founding Date 2011 | Founding Date 2008 |
Type | Type Public | Type Private | Type Public | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations Bala Cynwyd, US HQ | Locations Cleveland, US HQ | Locations New York, US HQ Jerusalem, IL | Locations Ann Arbor, US HQ | Locations Montgomery, US HQ |
Employees | Employees 782% decrease | Employees 1 | Employees 1417% increase | Employees 5 | Employees 3521% increase |
Valuation ($) | Valuation ($) 496.4 m | Valuation ($) N/A | Valuation ($) 94.2 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Net income | Net income ($165.7m) (FY, 2025) | Net income N/A | Net income $64m (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 132.2m | Total funding raised $ 722.5k | Total funding raised $ 1m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Lobesity
HQ
Cleveland, US
Employees
1
Lobesity (also known as Lobesity Investors) is a company engaged in the clinical and commercial development of therapies to treat obesity and related disorders.
View companyOramed Pharmaceuticals
HQ
New York, US
Employees
14↑ 17% increase
Oramed Pharmaceuticals is the developer of an innovative technology to transform injectable treatments into oral therapies.
View companyDiapin Therapeutics
HQ
Ann Arbor, US
Employees
5
Diapin Therapeutics is a biotech company focused on the treatment of Type 2 diabetes.
View companyKowa Pharmaceuticals America
HQ
Montgomery, US
Kowa Pharmaceuticals America is a pharmaceutical company focused on cardiometabolic diseases.
View company